Like insulin, treatment of cancer cells with α2M* upregulates Rictor protein levels (Figure 9A) and the phosphorylation of Akt at S473 by about 1.5–2-fold compared to buffer treated cells (Figure 9B and C). The gene discussed is INS; the disease is cancer.